BioLineRx Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. BE
9. BMY
10. PNFP

Go back to BioLineRx Reports Second Quarter 2015 Financial Results

Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following Q2 Results; BL-8040 Continues to be Main Driver

August 20, 2015 12:40 PM EDT

Roth Capital affirms BioLineRx (NASDAQ: BLRX) with a Buy rating and $7 price target after BLRX reported quarterly results earlier Thursday.

BLRX posted Q2 EPS of ($0.12), which was $0.04 worse than the analyst estimate of ($0.08).

Analyst Joseph Pantginis offered the following commentary, We currently view BL-8040 as the main value driver for the company with multiple near-term milestones expected. The most significant... More

BioLineRx (BLRX) Misses Q2 EPS by 4c

August 20, 2015 7:05 AM EDT

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

... More